Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®*, its Third Approved Biosimilar in the U.S.
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius, with an intravenous an…
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius, with an intravenous an…
When it comes to the fashion & ecommerce industries, time is of the essence. Styles change frequently as customer demand…
The Executive Board of thyssenkrupp Steel today presented initial conceptual outlines of a planned realignment of steel…
. • With key leadership decisions, Supervisory Board demonstrates confidence in the strategy and trajectory of Siemens A…
The 17th World Pultrusion Conference (WPC) took place from February 29 to March 1, 2024 with a record number of particip…
Karora Resources Inc. (TSX: KRR) ("Karora" or the "Company") - https://www.commodity-tv.com/... - today announced finan…
The technotrans Group continued its growth trajectory and ended the 2023 financial year with a 10 % increase in revenue…
Lonza has signed an agreement to acquire the Genentech manufacturing facility in Vacaville (US) from Roche for USD 1.2 b…
Fiscal year 2023 • Consolidated sales grow by 12% to €7,176 million • EBIT before purchase price allocation stands…
- Rheinmetall receives order for almost 100,000 artillery shells for Spanish army - Order worth over €200 million -…